Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Op-Eds
Washington Post Sells White House Access to Lobbyists
Until it was publicly-exposed, the Washington Post was selling its access to the White House to lobbyists. As Politico reported, “For $25,000 to $250,000,…
Op-Eds
Why The Madoff Sentence is Too Long
Bernard Madoff is an evil con man. He should spend the nearly all the rest of his miserable life in prison. But the 150-year…
Op-Eds
Eliminating Prison Rape
It has been far too long in coming but, yesterday, the Federal Prison Rape Elimination commission released its report on elimination and prevention efforts…
Op-Eds
Obama Signs “Deceptive” FDA Tobacco Regulation Bill
Yesterday, Obama signed into law a deceptive FDA “tobacco regulation” bill that will undermine public health in the long run by protecting cigarette manufacturers…
Citation
Jimmy P’s Top Ten Blogs Posts of the Day
Op-Eds
FDA’s Bad Medicine
President Barack Obama promised to shake up the Food and Drug Administration, so it’s no surprise that his new FDA leadership team has made…